• Featured
• Most Viewed
• Most Recent
• Most Comments

• AdvaMed2008 - (57)
• Aesthetics - (2)
• Cancer - (1)
• Cardiology - (8)
• Diabetes - (1)
• Diagnostics - (2)
• DrugDelivery - (3)
• European Tech Tour 2008 - (2)
• Health Tech Investment Fo... - (1)
• HIV / AIDS - (1)
• Imaging - (3)
• In3 East-Boston - (18)
• Infectious Disease - (1)
• OMP Financial Forum 2009 - (2)
• Oncology - (1)
• Ophthalmology - (3)
• Orthopedics - (1)
• Other - (10)
• Pain Management - (3)
• Pediatrics - (1)
• Pharmaceuticals - (2)
• Prostate - (4)
• Pulmonology - (1)
• Raw Interviews - (1)
• Resources - (32)
• Urology - (19)
• Venture Fund - (3)

•  

OneMedForum2010 OneMedForum Kent Hermsmeyer, PhD President Dimera Incorporated OneMedTV correspondent Alicia Ontiveros 2010 San Francisco advday3 AdvaMed2008 g-Nostics 6167 OneMedForum2010 OneMedForum Michael Langhout President CEO Silere Medical 2010 San Francisco OneMedForum2010 OneMedForum Ron Andrews CEO Clarient, Inc. William Dawson of LifeTech Capital 2010 San Francisco Arboretum Ventures OneMedForum2010 OneMedForum Denis Corin President TapImmune, Inc. William Dawson LifeTech Capital 2010 San Francisco urology gynecology gastroenterology endocrinology obstetrics nasal sprays injectables tablets ulcerative colitis Urology prostate urinary bladder erectile cancer erectile dysfunction bbstetrics infertility OneMedForum2010 OneMedForum Jeff Eliot Margolis CFO Xintria Pharmaceutical Corporation William Dawson LifeTech Capital 2010 San Francisco Acorn AdvaMed2007 1797 Public Company Report Bill Dawson Raafat Fahim Dr. Ph.D. CEO Nabi Pharmaceuticals OneMedForum2010 OneMedForum 2010 Access Pharmaceuticals octane, conference, medical, device, investors, investments, thomas fogarty OneMedForum2010 OneMedForum Stephen Simes President CEO BioSante Pharmaceuticals William Dawson LifeTech Capital 2010 San Francisco OneMedForum2010 OneMedForum 2010 TapImmune Presentation 2010 OneMedForum san francisco onemedtv, production, onemedplace